WINDISCHLEUBA, Germany and MISSOULA, Mont., March 11, 2011 /PRNewswire/ -- The Board of Directors of Global Immune Technologies, Inc. (OTC QB: GIMU) announces its plan to launch a Securities Awareness Campaign beginning March 14th, 2011 to March 10, 2012.
According to the company, a Securities Awareness Campaign is not unlike an advertising campaign, it is a series of advertisements and/or sponsored messages that share a single idea and theme to create awareness of the company's current and future objectives and potential with the intent to attract and interest investors and or stakeholders.
A securities awareness campaign may include the hiring of investor relations personnel, launching a new web based investor relations platform, sending emails to opt-in subscribers of newsletters and/or information websites, placing ads on websites, sponsoring research reports, interacting on message boards and mailing press kits and information. These services can be paid for and/or hired by the company with the issuance of restricted shares and/or cash. It is also possible that existing shareholders pay individuals and/or companies to perform these services and these shareholders could pay with the transfer of shares and/or cash. In either case, the company intends to provide whenever possible with a disclosure of said payment and/or hiring.
Shareholders and/or potential shareholders should be aware that a securities awareness campaign does not guarantee that a market will develop in the company's securities and that in the event an active market does develop, the price of the stock may not reflect the fundamental value of the company. It should be further noted that the shares are tightly held by few shareholders and this may have the result of a sudden increase in the price of the security and the same is true if the security is sold, it may result in a sudden drop in the price of the stock.
The company does not support in anyway the use of "spamming" and requests that shareholders immediately contact the company in the event they receive and/or are aware of such activity.
Further information can be obtained by telephoning Jeffrey R. Bruhjell +1 406 558 4947 firstname.lastname@example.org or by visiting www.renewunlimited.com, or Uwe Vincenz, Telefon: +49 3447 834448 www.iat-remsa.de or email: email@example.com
We seek Safe Harbour
SOURCE Global Immune Technologies, Inc.